nach oben

Erschienen in:

01.12.2011 | Original Article

Fatigue, Depression, Sleep, and Activity During Chemotherapy: Daily and Intraday Variation and Relationships Among Symptom Changes

verfasst von: Heather S. L. Jim, Ph.D., Brent Small, Ph.D., Leigh Anne Faul, Ph.D., Jamie Franzen, B.A, Sachin Apte, M.D., Paul B. Jacobsen, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Previous research suggests that cancer patients frequently experience multiple symptoms during chemotherapy; however, relationships among symptom changes are largely unknown.

Purpose

The aim of the current study was to examine daily and intraday changes and interrelationships among fatigue, depression, and objectively measured disruptions in sleep and activity during chemotherapy.

Methods

Participants were 78 women with gynecologic cancer. Fatigue, depression, sleep, and activity were assessed the week before and the week after the participants’ first three infusions.

Results

Significant changes in fatigue, depression, sleep, and activity were observed over time. Before infusions, increases in fatigue were associated with increases in depression. After infusions, increases in fatigue were associated with increases in depression and minutes awake at night, as well as decreases in daytime activity and regularity of sleep/activity patterns (ps < .05).

Conclusions

This study is among the first to track daily and intraday changes in symptoms and interrelationships during chemotherapy. Results indicate that symptoms are interrelated and return to baseline levels after infusions.

The equation used is as follows: y = b ₁ X _{infusion number} + b ₂ X _prechemo + b ₃ X _prechemo ² + b ₄ X _{infusion number}∙X _prechemo + b ₅ X _{infusion number}∙X _prechemo ² + b ₆ X _postchemo + b ₇ X _postchemo ² + b ₈ X _{infusion number}∙X _postchemo + b ₉ X _{infusion number}∙X _postchemo ² + c _.

Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004, 32:40–50.PubMedCrossRef

Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. European Journal of Cancer. 2002, 38:27–43.PubMedCrossRef

Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB: Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology. 2005, 23:6613–6622.PubMedCrossRefPubMedCentral

Medeiros M, Oshima CT, Forones NM: Depression and anxiety in colorectal cancer patients. J Gastrointest Cancer. 2010, 41:179–184.PubMedCrossRef

Iconomou G, Iconomou AV, Argyriou AA, et al.: Emotional distress in cancer patients at the beginning of chemotherapy and its relation to quality of life. J BUON. 2008, 13:217–222.PubMed

Palesh OG, Roscoe JA, Mustian KM, et al.: Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010, 28:292–298.PubMedCrossRefPubMedCentral

Savard J, Villa J, Ivers H, Simard S, Morin CM: Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009, 27:5233–5239.PubMedCrossRef

Beesley VL, Price MA, Butow PN, et al. (2011) Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life. Psychooncology (in press).

Stephenson LE, Bebb DG, Reimer RA, Culos-Reed SN: Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: Associations with quality of life. BMC Gastroenterol. 2009, 9:60.PubMedCrossRefPubMedCentral

10.

Beck SL, Berger AM, Barsevick AM, et al.: Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer. 2010, 18:679–689.PubMedCrossRefPubMedCentral

11.

Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM: Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum. 2010, 37:E359–369.PubMedCrossRef

12.

Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L (2010) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18(1):105–114PubMedCrossRef

13.

Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 1998, 16:1689–1696.PubMed

14.

Redeker NS, Lev EL, Ruggiero J: Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Scholarly Inquiry for Nursing Practice. 2000, 14:275–290; discussion 291–278PubMed

15.

Mormont MC, Waterhouse J: Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiology International. 2002, 19:313–323.PubMedCrossRef

16.

Munir F, Yarker J, McDermott H: Employment and the common cancers: Correlates of work ability during or following cancer treatment. Occup Med (Lond). 2009, 59:381–389.PubMedCrossRef

17.

Curt GA, Breitbart W, Cella D, et al.: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist. 2000, 5:353–360.PubMedCrossRef

18.

Tiedtke C, de Rijk A, Dierckx de Casterle B, Christiaens MR, Donceel P: Experiences and concerns about ‘returning to work’ for women breast cancer survivors: A literature review. Psychooncology. 2010, 19:677–683.PubMedCrossRef

19.

Gupta D, Lis CG, Grutsch JF: The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 2007, 34:40–47.PubMedCrossRef

20.

Poulson MJ: Not just tired. J Clin Oncol. 2001, 19:4180–4181.PubMed

21.

Savard J, Liu L, Natarajan L, et al.: Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009, 32:1155–1160.PubMedPubMedCentral

22.

Liu L, Fiorentino L, Natarajan L, et al.: Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009, 18:187–194.PubMedCrossRefPubMedCentral

23.

Berger AM, Higginbotham P: Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncology Nursing Forum. 2000, 27:1443–1448.PubMed

24.

de Jong N, Kester AD, Schouten HC, Abu-Saad HH, Courtens AM: Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs. 2006, 29:467–477.PubMedCrossRef

25.

Jacobsen PB, Hann DM, Azzarello LM, et al.: Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. Journal of Pain and Symptom Management. 1999, 18:233–242.PubMedCrossRef

26.

Ancoli-Israel S, Liu L, Marler MR, et al.: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006, 14:201–209.PubMedCrossRefPubMedCentral

27.

Berger AM, Farr L: The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncology Nursing Forum. 1999, 26:1663–1671.PubMed

28.

Donovan KA, Jacobsen PB: Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Semin Oncol Nurs. 2007, 23:127–135.PubMedCrossRef

29.

Stevinson C, Steed H, Faught W, et al.: Physical activity in ovarian cancer survivors: Associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer. 2009, 19:73–78.PubMedCrossRef

30.

Servaes P, Verhagen CA, Bleijenberg G: Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: Daily self-report and objective behavior. Cancer. 2002, 95:2017–2026.PubMedCrossRef

31.

Roscoe JA, Morrow GR, Hickok JT, et al.: Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Supportive Care in Cancer. 2002, 10:329–336.PubMedCrossRef

32.

Palesh OG, Collie K, Batiuchok D, et al.: A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007, 75:37–44.PubMedCrossRefPubMedCentral

33.

Badr H, Basen-Engquist K, Carmack Taylor CL, De Moor C: Mood states associated with transitory physical symptoms among breast and ovarian cancer survivors. J Behav Med. 2006, 29:461–475.PubMedCrossRef

34.

Holzner B, Kemmler G, Meraner V, et al.: Fatigue in ovarian carcinoma patients: A neglected issue? Cancer. 2003, 97:1564–1572.PubMedCrossRef

35.

Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al.: Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology. 2000, 78:302–308.PubMedCrossRef

36.

Fox SW, Lyon D: Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007, 30:354–361.PubMedCrossRef

37.

Morgan RJ, Alvarez RD, Armstrong DK, et al.: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Retrieved Sept. 23, 2009 from http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf

38.

Webster JB, Kripke DF, Messin S, Mullaney DJ, Wyborney G: An activity-based sleep monitor system for ambulatory use. Sleep. 1982, 5:389–399.PubMed

39.

Patterson SM, Krantz DS, Montgomery LC, et al.: Automated physical activity monitoring: Validation and comparison with physiological and self-report measures. Psychophysiology. 1993, 30:296–305.PubMedCrossRef

40.

Sugimoto A, Hara Y, Findley TW, Yonemoto K: A useful method for measuring daily physical activity by a three-direction monitor. Scandanavian Journal of Rehabilitation Medicine. 1997, 29:37–42.

41.

Berger AM, Wielgus KK, Young-McCaughan S, et al.: Methodological challenges when using actigraphy in research. Journal of Pain and Symptom Management. 2008, 36:191–199.PubMedCrossRefPubMedCentral

42.

Rich T, Innominato PF, Boerner J, et al.: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research. 2005, 11:1757–1764.PubMedCrossRef

43.

Mormont MC, Langouet AM, Claustrat B, et al.: Marker rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status. Chronobiology International. 2002, 19:141–155.PubMedCrossRef

44.

Wainer H: Piecewise regression: A simplified procedure. British Journal of Mathematical and Statistical Psychology. 1971, 24:83–92.PubMedCrossRef

45.

McGee VE, Carleton WT: Piecewise regression. Journal of the American Statistical Association. 1970, 65:1109–1124.CrossRef

46.

Rumble ME, Keefe FJ, Edinger JD, et al.: Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: A daily process analysis. Sleep. 2010, 33:1501–1509.PubMedPubMedCentral

47.

Payne J, Piper B, Rabinowitz I, Zimmerman B: Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: A pilot study. Oncol Nurs Forum. 2006, 33:775–783.PubMedCrossRef

48.

Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008, 26:971–982.PubMedCrossRefPubMedCentral

Titel: Fatigue, Depression, Sleep, and Activity During Chemotherapy: Daily and Intraday Variation and Relationships Among Symptom Changes
verfasst von: Heather S. L. Jim, Ph.D.
Brent Small, Ph.D.
Leigh Anne Faul, Ph.D.
Jamie Franzen, B.A
Sachin Apte, M.D.
Paul B. Jacobsen, Ph.D.
Publikationsdatum: 01.12.2011
Verlag: Springer US
Erschienen in: Annals of Behavioral Medicine / Ausgabe 3/2011
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-011-9294-9

Springer Medizin

Fatigue, Depression, Sleep, and Activity During Chemotherapy: Daily and Intraday Variation and Relationships Among Symptom Changes